Terms: = Lung cancer AND CUX1, ENSG00000160967, P39880, p75, p200, p110, p100, Nbla10317, CUX, COY1, CDP, CASP, 1523 AND Clinical Outcome
3 results:
1. The Dissociation of Gefitinib Trough Concentration and clinical outcome in NSCLC Patients with EGFR Sensitive Mutations.
Xin S; Zhao Y; Wang X; Huang Y; Zhang J; Guo Y; Li J; Li H; Ma Y; Chen L; Hu Z; Huang M; Zhang L
Sci Rep; 2015 Jul; 5():12675. PubMed ID: 26228025
[TBL] [Abstract] [Full Text] [Related]
2. Molecular pathways: targeting phosphoinositide 3-kinase p110-delta in chronic lymphocytic leukemia.
Herman SE; Johnson AJ
Clin Cancer Res; 2012 Aug; 18(15):4013-8. PubMed ID: 22711705
[TBL] [Abstract] [Full Text] [Related]
3. High level amplification of 1p32-33 and 2p22-24 in small cell lung carcinomas.
Lui WO; Tanenbaum DM; Larsson C
Int J Oncol; 2001 Sep; 19(3):451-7. PubMed ID: 11494021
[TBL] [Abstract] [Full Text] [Related]
